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Aeromonas-associated diarrhea 619Results: Thirteen (2.5 %) of 514 diarrheal patients and six (3.6%) of 167 asymptomatic controls
had Aeromonas isolates in their stools. Of 11 diarrheal patients with available clinical informa-
tion, Aeromonas veronii, the predominant species, was noted in six patients, and another po-
tential enteropathogen was present in four patients. The cytotoxicity of A. veronii isolates to
the HT-29 cell line was more potent in the isolates from diarrheal patients than those from
asymptomatic controls (p Z 0.015). The cytotoxicity of A. veronii isolates was more potent
than that of A. caviae from symptomatic patients (p Z 0.001). Putative virulence markers,
including AHCYTONE, ascV, ascF-ascG, and aexT, were detected exclusively in A. veronii.
The presence of the ascV gene was associated with cytotoxicity in A. veronii isolates. All Aero-
monas isolates were susceptible to varied antimicrobial agents, except ampicillin/sulbactam.
Conclusion: A. veronii is the predominant species in stools from individuals with or without
diarrhea in southern Taiwan.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Aeromonas species are important endemic pathogens in
southern Taiwan, in which a variety of human Aeromonas
infections, such as bacteremia, biliary tract infection,
soft tissue infection, and pneumonia, have been
reported.1e4 In contrast, Aeromonas-associated intestinal
infections in this area were rarely mentioned. Although
Aeromonas-associated intestinal infections have been
reported and discussed in the literature,5e8 there are still
several controversies about its role as an enteropathogen.
The arguments about aeromonads as a true enter-
opathogen, summarized in a review by von Graevenitz,9
come from several lines of evidence: (1) failure to iden-
tify a single clonally-related outbreak of diarrhea caused
by these pathogens, even though they are ubiquitous in
environments; (2) the lack of proven experimental path-
ogenicity for humans; and (3) frequently a self-limited
clinical course of Aeromonas-associated diarrhea. How-
ever, with the advance of molecular techniques, more
Aeromonas species are considered the causes of diarrhea,
and the number of enterotoxins responsible for enteritis
has been identified increasingly.10 At least infraspecific
subsets of Aeromonas strains with a particular array of
enterotoxin genes are suggested to be potential
enteropathogens.9
Several virulence factors have been considered to play
an important role in causing gastrointestinal infections,
such as type IV pili,11 heat-labile enterotoxins (Act and Alt),
heat-stable enterotoxin (Ast), a variety of hemolysins
(AerA, HlyA, Ahh1, and Asa1), and type III secretion system
(TTSS).10e14 Some clinical studies have found that the
cytotoxin was more frequently present in Aeromonas iso-
lates from diarrheal patients than in the carriers.15 How-
ever, controversy remains because some reports showed
contradictory results.16
In Taiwan, diarrheal patients are often screened by
clinical microbiology laboratories for several bacterial
pathogens, such as Campylobacter, Shigella, or Salmonella
species, but not for Aeromonas species. Therefore, our
study aim was to study the frequency of isolation and
clinical significance of aeromonads in fecal specimens, aswell as their antimicrobial susceptibility, cytotoxicity, and
virulence factors among fecal Aeromonas isolates obtained
from diarrheal and asymptomatic patients.Materials and methods
Cultivation and identification of Aeromonas
isolates
This prospective study was conducted at the National
Cheng Kung University Hospital, a medical center in
southern Taiwan between September 2010 and December
2011. The stool samples from symptomatic patients for
microbiological cultures of Salmonella, Shigella, or Vibrio
species, were screened for Aeromonas species using the
Aeromonas Selective Medium LabM 167 (Lab M; Lab M Ltd,
Lancashire, UK) in the microbiological laboratory. Patients
undergoing health examinations in the study hospital were
recruited for participation (as the control group), and their
stool samples were screened for aeromonads using the
method described above.
The genus Aeromonas was identified as previously
described.17 Aeromonas isolates were stored at 70C until
use. Final species identification was made through the
partial sequences of rpoD.18 The reference strains for rpoD
sequencing (GenBank accession no.) included Aeromonas
dhakensis (Aeromonas aquariorum MDC47, FJ936132.1),
Aeromonas veronii ATCC 9071T (FN773340.1), Aeromonas
caviae ATCC 13136T (FN773319.1), and Aeromonas sanar-
ellii A2-67T (FJ472929.1).Antimicrobial susceptibility
The performance procedures for antimicrobial susceptibil-
ity by the disk diffusion method and the interpretative
criteria were interpreted following the Clinical and Labo-
ratory Standards Institute recommendations for Aeromonas
species.19 The antimicrobial agents tested included amox-
icillin/sulbactam, cefuroxime, ceftriaxone, cefepime, lev-
ofloxacin, and imipenem.
Figure 1. Isolation rates of Aeromonas species in the stools
from individuals with and without diarrhea in different age
groups. The p value of the trend test for diarrhea (-) and no
diarrhea (,) is 0.07 and 0.41, respectively.
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All isolates were studied by polymerase chain reaction to
identify the genes encoding putative virulence factors:
cytolytic enterotoxin (AHCYTOEN), aerolysin (aerA), hemo-
lysin (hlyA), heat-labile enterotoxin (alt), heat-stable
enterotoxin (ast), and three components of the TTSSdascV,
aexT, and ascF-ascGdas described elsewhere.20
Cytotoxicity of Aeromonas isolates
Fecal Aeromonas isolates were tested for cytotoxicity to
the human colon carcinoma cell line, HT-29, according to a
previously described method.10 A 0.1% Triton X-100 solution
was used as a positive control and serum-free RPMI (Roswell
Park Memorial Institute) medium (GIBCO, Grand Island, NY,
USA) as a negative control. The cytotoxic activity was
expressed as the mean of triplicate measurements of
released leukocyte lactate dehydrogenase levels,
compared with that of Triton X-100 solution (defined as
100% of cytotoxicity).
Patient information
Symptomatic patients with Aeromonas species in their
stools were investigated for their clinical presentations, if
informed consent was obtained. The information reviewed
included demographic data, food and occupation exposure
history, and clinical presentations. The study was ethically
approved by the Institutional Review Board of the study
hospital (IRB no. ER-99-086).
Statistical analysis
Categorical variables were compared using the Chi-square
test or Fisher’s exact test, if the expected counts were less
than 5. The median cytotoxicity was compared using the
ManneWhitney test and plotted using GraphPad Prism,
version 5.01 (GraphPad Software Inc., La Jolla, CA, USA).
The CochraneArmitage trending statistic test was per-
formed to assess the relationship between the incidence of
Aeromonas-associated diarrhea and age.
Results
During the study period, stool samples were collected from
514 adults (18 years old) with diarrhea in the study hos-
pital. In addition, 167 stool specimens were obtained from
individuals undergoing health examinations during the
study period. Of 514 patients with diarrhea, 13 (2.5%) had
Aeromonas isolates in unformed stools. In contrast, 6 (3.6%)
of 167 asymptomatic persons had Aeromonas in their stools.
A total of 19 Aeromonas stool isolates were identified as A.
veronii (10, 52.6%), A. caviae (7, 36.8%), A. sanarelli (1,
5.3%), and A. dhakensis (1, 5.3%), based on the matched
rpoD sequences. The distribution of Aeromonas species in
patients with and without diarrhea was similar (p Z 0.72).
The Aeromonas isolation rates among stool samples in
different age stratification are given in Fig. 1. Our data
showed a linear trend of the proportion of Aeromonasspecies recovered from individuals with diarrhea increasing
with age (pZ 0.07). Ten of 13 diarrheal episodes occurred
during the summer season (AprileSeptember) in southern
Taiwan.
Informed consent was obtained from 11 of 13 symp-
tomatic patients, and their clinical features are summa-
rized in Table 1. In addition to diarrhea, their clinical
presentations included abdominal cramping pain (3 pa-
tients), nausea/vomiting (1 patient), dysentery (1 patient),
and fever (1 patient). Copathogens, including Clostridium
difficile [2 patients with fecal growth of C. difficile and
1patient with fecal C. difficile toxin as revealed by: PRE-
MIER  TOXINS A&B (Meridian Bioscience, Inc., Cincinnati,
Ohio, USA), and Vibrio parahaemolyticus (1 patient), were
noted. Eleven Aeromonas isolates were identified as A.
veronii (6 patients), A. caviae (3 patients), A. dhakensis (1
patient), and A. sanarellii (1 patient). Their median age
was 73 (range, 35e87) years. The underlying diseases of 11
patients included liver cirrhosis (2 patients), malignancy (2
patients), diabetes mellitus (2 patients), and Crohn’s dis-
ease (1 patient). One patient had a history of eating lettuce
with salad prior to the illness. Nine of 11 patients were
admitted for medical care, and eight were treated by an-
tibiotics. Although diarrhea lasting for more than 1 month
was noted in two patients, enteritis symptoms resolved
within 2 weeks in eight patients. Of note, a patient from
whose stool A. veronii and C. difficile toxins were detec-
ted, developed severe colitis and hypotension requiring
vasopressor support.
The identified virulence genes, includingdAHCYTOEN,
ascF-ascG, ascV, aexT, and hlyAdinAeromonas stool isolates
frompatientswithdiarrhea are summarized inTable 1. Three
genes, aerA, ast, and alt, were not detected. Of note, in five
clinical A. veronii isolates, some putative virulencemarkers,
including AHCYTOEN (4 isolates), ascF-ascG (3 isolates), ascV
(3 isolates), aexT (1 isolate), and hlyA (1 isolate), were
identified. All 19 isolates were susceptible to cefuroxime,
ceftriaxone, cefepime, levofloxacin, and imipenem (Table
2). In contrast, the majority (94.7%) of isolates were not
susceptible to ampicillin/sulbactam.
The cytotoxicity of Aeromonas isolates from the in-
dividuals with and without diarrhea, as assessed in the HT-
Figure 2. The medians with interquartiles of cytotoxicity for
fecal Aeromonas veronii and Aeromonas caviae isolates from
individuals with and without diarrhea.
Table 1 Clinical features of 11 patients with Aeromonas-
associated diarrhea
Characteristics No. of patients (%)
Age (median, range), y 73, 35e87
Sex, male 8 (72.7)
Underlying disease
Diabetes mellitus 2 (18.2)
Malignancy 2 (18.2)
Liver cirrhosis 2 (18.2)
HIV/AIDS 1 (9.1)
Crohn’s disease 1 (9.1)
Treatment for diarrhea
Admission 9 (81.8)
Antibiotic treatment 8 (72.7)
Clinical presentations
Leukocytosis 5 (45.5)
Fever 3 (27.3)
Diarrhea >2 wk 2 (18.2)
Aeromonas species
A. veronii 6 (54.6)
A. caviae 3 (27.3)
A. sanarellii 1 (9.1)
A. dhakensis 1 (9.1)
Virulence genes
AHCYTOEN 4 (36.4)
ascF-ascG 4 (36.4)
ascV 3 (27.3)
aexT 1 (9.1)
hlyA 1 (9.1)
Virulent strainsa 5 (45.5)
Concurrent enteropathogens
Clostridium difficileb 3 (27.3)
Vibrio parahaemolyticus 1 (9.1)
a Defined as cytotoxicity > 50%, based on the released
leukocyte lactate dehydrogenase level, as compared with that
of Triton X-100 solution, which is defined as 100% of cytotoxicity
in the HT-29 cell line.
b Clostridium difficile toxin A/B or toxigenic C. difficile was
detected in stool.
Aeromonas-associated diarrhea 62129 cell line, is shown in Fig. 2. Five of 11 patients with
diarrhea were infected with Aeromonas isolates with a
cytotoxicity level of >50%. The median values of cytotox-
icity levels for fecal A. veronii isolates from diarrhealTable 2 In vitro susceptibility of Aeromonas stool isolates to si
Drugs A. veronii
(n Z 10)
S I R
Ampicillin/sulbactam 0 1 (10) 9 (90)
Cefuroxime 10 (100) 0 0
Ceftriaxone 10 (100) 0 0
Cefepime 10 (100) 0 0
Levofloxacin 10 (100) 0 0
Imipenem 10 (100) 0 0
I Z intermediate; R Z resistant; S Z susceptible.patients were higher than those from asymptomatic con-
trols (63.1% vs. 21.9%, p Z 0.015). Nonetheless, the cyto-
toxicity of A. caviae isolates obtained from individuals with
and without diarrhea was similar (10.7% vs. 7.30%,
pZ 0.46). However, cytotoxicity was more evident in fecal
A. veronii than in A. caviae isolates from symptomatic pa-
tients (63.1% vs. 10.7%, p Z 0.001). With regard to the
correlation and virulence factors, the cytotoxicity was
more evident in ascVþ A. veronii isolates (73.0% vs. 26.2%,
p Z 0.008).
Two A. veronii isolates from the patients with concom-
itant V. parahaemolyticus or C. difficile toxin in feces
expressed high cytotoxicity levels (92.4% and 91.5%,
respectively). In contrast, low cytotoxicity levels (15.9%
and 21.7%, respectively) were present in an A. veronii
isolate from a patient with healthcare-associated diarrhea,
and an A. caviae isolate from a patient with AIDS and
diarrhea. Although C. difficile was isolated from the stool
samples of both patients, the toxigenic status of C. difficile
isolates was not determined.x antimicrobial agents
A. caviae
(n Z 7)
Aeromonas isolates
(n Z 19)
S I R S
0 1 (14.3) 6 (85.7) 1 (5.3)
7 (100) 0 0 19 (100)
7 (100) 0 0 19 (100)
7 (100) 0 0 19 (100)
7 (100) 0 0 19 (100)
7 (100) 0 0 19 (100)
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In Taiwan, invasive Aeromonas infections were more often
reported than Aeromonas-associated diarrhea. In the pre-
sent study, the isolation rate in clinical stool samples from
diarrheal patients was 2.5%, which is comparable with the
isolation rates reported in Spain (2%), Sweden (2%), Israel
(2%), Switzerland (4.8%), and Japan (5.6%),6,21e24 and is
similar to that in our asymptomatic controls (4.2%) and
healthy individuals in Tokyo (3.8%, 74/1958 patients).24
However, the isolation rates varied widely in different
countries. For example, up to 52.4% of diarrheal infants and
8.7% in controls were reported in Peru.25
Similar to our previous observation of seasonal prefer-
ence of Aeromonas bacteremia,1,26 the predominance of
our cases of Aeromonas-associated diarrhea was evident in
warm seasons, which is probably related to the prolifera-
tion of aeromonads in water systems in higher ambient
temperatures.27 Although the trend test was not signifi-
cant, the elderly have an increased risk of acquiring Aero-
monas-associated diarrhea in this study. Similar findings of
Aeromonas bacteremia have been reported.28 Greater
susceptibility to Aeromonas infections in the elderly may be
related to concurrent chronic underlying diseases and
waning host immunity.28,29 Therefore, physicians should
consider Aeromonas spp. as one of the possible enter-
opathogens causing gastrointestinal infections in the sus-
ceptible population.
The result that A. veronii was the predominant species
in adults was not in accordance with other reports. In
northern Taiwan, Aeromonas hydrophila has been discov-
ered in 2.5% of 2150 diarrheal stool samples from chil-
dren.30 In a review article, A. caviae was referred to be the
most common species, followed by A. hydrophila and Aer-
omonas veronii biovar sobria.9 Among the etiologies of
travelers’ diarrhea among Finnish tourists traveling to
Morocco, A. veronii biovar. sobria was the major species.31
These varied results may be related to heterogeneous
hosts, geographic locations, season of collections, and
different culture media used.5 Of note, A. sanarellii was
isolated from a female presenting to the emergency
department with diarrhea as well as urinary tract infection.
She recovered after taking oral cephalexin (for 3 days),
which was not in vitro active against A. sanarellii, for uri-
nary tract infection. A. sanarellii has been first identified in
Taiwan and associated with clinical wounds in humans.3,32
Although further clinical evidence is required to confirm
the enteropathogenicity of A. sanarellii in humans, this is
the first report to describe the isolation of A. sanarellii
from human stools.
Although many cases of diarrheal disease due to Aero-
monas were mild, 82% (9/11 patients) of our cases were
admitted and 73% (8/11 patients) received antibiotics,
indicating severe illness in certain cases. Despite the fact
that the role of antimicrobial therapy remains controversial
for Aeromonas-associated diarrhea, most Aeromonas iso-
lates were susceptible to broad-spectrum beta-lactams and
fluoroquinolone. However, the clinical use of cephalothin,
ampicillin, or ampicillin/sulbactam for Aeromonas-associ-
ated diarrhea will be discouraged because of antimicrobial
resistance.20,33Our study indicated that cytotoxicity levels were
significantly higher in A. veronii isolates from diarrheal
patients, in accordance with several published studies in
which a significant association was found between cyto-
toxicity in cell lines and clinical diarrheal disease.34,35 For
example, in an Iranian study, cytotoxicity was present in
67.9% of A. hydrophila isolates from diarrheal patients, in
contrast to 22.7% in asymptomatic persons (p < 0.05).34
Moreover, the ascV gene encoding the TTSS has been
considered an indicator of virulence in Aeromonas,36,37
which was further supported by our finding that cytotox-
icity was more evident in ascVþ isolates than in ascV
isolates.
Although there were similar Aeromonas isolation rates
from the stools of individuals with and without diarrhea,
the microbiological characteristic suggests that A. veronii is
a potent enteropathogen. Cytotoxicity was present in
clinical A. veronii isolates, which carry an array of genes
encoding virulence factors. Of note, a significant proportion
of A. veronii isolates carried genes encoding a cytotoxin,
AHCYTONE, and the components of TTSS (ascV and ascF-
ascG). Moreover, the variable cytotoxicity among A. veronii
isolates indicates that the colonization of nonpathogenic or
low-level pathogenic Aeromonas isolates in the intestinal
tracts of humans is possible. In contrast, the pathologic role
of A. caviae in enteritis, at least in our study, is equivocal
owing to the absence of known virulence factors and
cytotoxicity in clinical isolates.
Gastroenteritis due to coinfections with Aeromonas and
other enteropathogens have been rarely reported. A
Spanish study of the role of Aeromonas species in travelers’
diarrhea found that three (16.7%) of 18 patients with Aer-
omonas infections had other enteropathogens, such as
Shigella sonnei, Giardia lamblia, or Salmonella typhimu-
rium.6 Moreover, four (36.4%) of our 11 patients with Aer-
omonas-associated diarrhea had another enteropathogen,
either C. difficile or V. parahaemolyticus, in their stools.
However, the enteropathogenicity or toxigenic status of the
two C. difficile isolates was not confirmed. These results of
the presence of concurrent enteropathogens and similar
isolation rates of Aeromonas species from stool samples of
individuals with and without diarrhea, not surprisingly,
raise some concern regarding the enteropathogenicity of
Aeromonas species in humans, a point of controversy raised
by von Graevenitz.9 However, many experts still include
Aeromonas species in the list of enteropathogens of trav-
elers’ diarrhea,38 acute dysentery,39 or chronic diarrhea.40
In conclusion, A. veronii is the predominant species
among fecal Aeromonas isolates, and its cytotoxicity was
more evident in the isolates from diarrheal patients than
from asymptomatic controls.
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